Pieris Pharmaceuticals, Inc.

NASDAQ:PIRS

16.9825 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 00.0531.29919.5220.0551.9365.8465.373.69810.9888.4434.0573.28515.6331.8772.93911.24613.26117.2715.1325.3328.5454.9148.34511.6914.15218.1523.9271.8531.3432.7260.7851.0731.2472.1390.415-003.280.0190.6981.3733.4260
Cost of Revenue 0.751-0.034.4540.7390.7250.5710.5850.77211.9470.840.58818.93715.816.56210.61811.82211.33312.75814.11613.21113.37314.2960000000000002,931.9310-0.16-0.217000000
Gross Profit -0.7510.083-3.15518.78119.331.3655.2614.598-8.24910.1487.855-14.88-12.515-0.929-8.741-8.883-0.0870.5033.1541.921-8.041-5.7514.9148.34511.6914.15218.1523.9271.8531.3432.7260.7851.0731.247-2,929.7920.4150.160.2183.280.0190.6981.3733.4260
Gross Profit Ratio 01.566-2.4290.9620.9640.7050.90.856-2.2310.9240.93-3.668-3.81-0.059-4.657-3.022-0.0080.0380.1830.127-1.508-0.673111111111111-1,369.4091-656.738574.198111110
Reseach & Development Expenses 0.7511.2484.4549.59514.32813.42413.3813.58911.94714.06615.35718.93715.816.56210.61811.82211.33312.75814.11613.21113.37314.29612.99811.4019.1557.9365.276.2595.3965.366.9174.6224.53.6592.9432.0521.7261.5252.330.9271.1191.2231.8490
General & Administrative Expenses 3.4264.1382.3276.8393.6644.0233.9853.9494.0814.3794.0854.1324.2464.133.674.1164.5684.3594.4844.8354.1894.9324.5644.7484.7794.3526.3942.8524.3493.9892.2142.3412.3681.9681.7622.2431.9692.3942.860.0140.0060.0020.0020.006
Selling & Marketing Expenses 00000000000000000000000000000000000000000000
SG&A 3.4264.1382.3276.8393.6644.0233.9853.9494.0814.3794.0854.1324.2464.133.674.1164.5684.3594.4844.8354.1894.9324.5644.7484.7794.3526.3942.8524.3493.9892.2142.3412.3681.9681.7622.2431.9692.3942.860.0140.0060.0020.0020.006
Other Expenses 0.3860.17115.5950.506-0.161-2.028-3.391-1.4680.676-2.13-1.0950.6780.4640.884-1.833-1.339-0.424-0.060.177-0.0550.023-0.1710.3311.1471.23-0.9030.995-1.729-1.380.0120.006-0.018-0.0880.220.011-0.0020.0040.001-000000
Operating Expenses 4.1775.3866.78116.43416.40815.41913.97416.0714.84416.31518.34721.27519.2520.69214.28815.93815.90117.11718.618.04617.56219.22817.56216.14913.93412.28811.6649.1129.7449.3499.1316.9636.8685.6274.7054.2943.5353.7015.190.0140.0060.0020.0020.006
Operating Income -4.177-5.303-5.482-11.8072.063-15.511-11.519-12.168-12.33-7.457-10.999-19.012-16.761-5.059-12.411-12.999-4.655-3.856-1.33-2.914-12.23-10.683-12.648-7.804-2.243-8.1366.487-5.184-7.891-8.006-6.405-6.178-5.795-4.381-2.565-3.88-3.534-3.701-1.515-0.014-0.006-0.002-0.002-0.006
Operating Income Ratio 0-100.057-4.22-0.6050.103-8.012-1.97-2.266-3.334-0.679-1.303-4.686-5.102-0.324-6.612-4.423-0.414-0.291-0.077-0.193-2.294-1.25-2.574-0.935-0.192-1.960.357-1.32-4.259-5.96-2.35-7.87-5.401-3.513-1.199-9.35814,485-9,766.05-0.462-0.743-0.009-0.001-0.0010
Total Other Income Expenses Net 0.5870.4110.898-14.387-0.1612.3283.4172.4320.6762.3561.4670.6780.4640.884-1.833-1.339-0.424-0.060.177-0.0550.023-0.1710.3311.1471.23-0.9030.995-1.729-1.380.0120.006-0.018-0.0880.220.011-0.0020.0040.001-2.655-0.181-0.112-0.109-0.1090
Income Before Tax -3.59-4.892-4.584-10.7523.976-13.183-8.102-9.736-10.338-5.101-9.532-16.536-15.498-4.172-14.236-14.283-4.95-3.597-0.771-2.592-11.758-10.348-11.846-6.153-0.351-8.7147.634-6.913-9.271-7.994-6.397-6.196-5.883-4.161-2.739-3.882-3.53-3.705-4.17-0.014-0.006-0.002-0.002-0.006
Income Before Tax Ratio 0-92.302-3.529-0.5510.198-6.809-1.386-1.813-2.796-0.464-1.129-4.076-4.718-0.267-7.584-4.86-0.44-0.271-0.045-0.171-2.205-1.211-2.411-0.737-0.03-2.0990.421-1.76-5.004-5.951-2.347-7.893-5.483-3.337-1.28-9.36314,467-9,775.024-1.271-0.743-0.009-0.001-0.0010
Income Tax Expense 0-0.073-0.69914.344-0.49-0.871-0.026-1.205-0.132-2.356-0.372-0.682-0.467-0.8871.9891.2840.295-0.259-0.559-0.322-0.472-0.335-0.164-1.651-0.1480.5780.1440.1460.814-0.0120.040.0180.012-0.220.1630.04-0.0040.0032.655-0.27-0.2060-0.2060
Net Income -3.59-4.892-4.584-10.7523.976-12.312-8.076-8.531-10.338-2.745-9.16-16.536-15.498-4.172-14.4-14.283-4.95-3.597-0.771-2.592-11.758-10.348-11.682-6.153-0.203-8.7147.49-7.059-10.085-7.994-6.559-6.196-5.883-4.161-2.902-3.922-3.53-3.705-6.825-0.014-0.006-0.002-0.002-0.006
Net Income Ratio 0-92.302-3.529-0.5510.198-6.36-1.381-1.589-2.796-0.25-1.085-4.076-4.718-0.267-7.672-4.86-0.44-0.271-0.045-0.171-2.205-1.211-2.377-0.737-0.017-2.0990.413-1.797-5.443-5.951-2.406-7.893-5.483-3.337-1.356-9.4614,467-9,775.024-2.081-0.743-0.009-0.001-0.0010
EPS -2.76-3.95-3.71-8.73.63-13.22-8.68-9.17-0.14-2.98-10.16-19.53-20.03-5.93-20.57-21.03-7.56-5.21-1.16-4.2-19.12-16.27-17.26-9.1-0.3-13.9313.36-12.72-18.59-14.85-12.18-11.51-11.52-8.36-5.83-8.07-9.6-10.12-14.29-0.029-0.013-0.003-0.004-0.01
EPS Diluted -2.76-3.95-3.71-8.73.63-13.22-8.68-9.17-0.14-2.98-10.16-19.53-20.03-5.93-20.57-21.03-7.56-5.21-1.16-4.2-19.12-16.27-17.26-9.1-0.3-13.9313.36-12.72-18.59-14.85-12.18-11.51-11.52-8.36-5.83-8.07-9.6-10.12-14.29-0.029-0.013-0.003-0.004-0.01
EBITDA -4.177-5.333-5.70518.6874.372-13.483-8.128-10.7-10.563-4.258-9.904-16.632-15.371-4.459-11.804-12.504-4.168-3.318-0.657-2.755-12.188-10.517-12.483-7.674-2.102-8.0026.588-5.184-7.778-8.006-6.333-6.104-5.883-4.067-2.555-3.882-3.454-3.622-1.425-0.014-0.006-0.002-0.002-0.006
EBITDA Ratio 0-100.623-4.3920.9570.218-6.964-1.39-1.993-2.856-0.388-1.173-4.1-4.679-0.285-6.289-4.255-0.371-0.25-0.038-0.182-2.286-1.231-2.54-0.92-0.18-1.9270.363-1.32-4.198-5.96-2.323-7.775-5.483-3.261-1.194-9.36314,153-9,557.908-0.435-0.743-0.009-0.001-0.0010